Mucinous Tubular and Spindle Cell Carcinoma: Case Report and Literature Review
Main Article Content
Keywords
renal cell carcinoma, kidney neoplasms, mucinous tubular and spindle cell carcinoma
Abstract
Mucinous tubular and spindle cell carcinoma (MTSCC) is a rare type of renal cell carcinoma (RCC) recognized as an independent entity in the latest WHO (World Health Organization) classification. We here report a case of a 51-year-old female patient with MTSCC, who presented with abdominal pain and left lower pole kidney lesion on the computed tomography scan. A robotic-assisted laparoscopic partial nephrectomy was performed. The diagnosis was confirmed on histopathological examination. MTSCC is rare and generally indolent. Either partial or radical nephrectomy is usually curative. The prognosis is usually favorable. However, occasionally, MTSCC could demonstrate aggressive features requiring systemic therapy. There are also several mimickers of MTSCC, which carry different prognostic and treatment profiles. Histological, immunohistochemical, and molecular genetic profile are useful in diagnosing the disease.
References
2. Srigley JR, Delahunt B, Eble JN, Egevad L, Epstein JI, Grignon D, et al. The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia. Am J Surg Pathol. 2013;37(10):1469–89. 10.1097/PAS.0b013e318299f2d1
3. Ged Y, Chen YB, Knezevic A, Donoghue MTA, Carlo MI, Lee CH, et al. Mucinous tubular and spindle-cell carcinoma of the kidney: Clinical features, genomic profiles, and treatment outcomes. Clin Genitourin Cancer. 2019;17(4):268–74.e1. 10.1016/j.clgc.2019.04.006
4. Kang H, Xu W, Chang S, Yuan J, Bai X, Zhang J, et al. Mucinous tubular and spindle cell carcinomas of the kidney (MTSCC-Ks): CT and MR imaging characteristics. Jpn J Radiol. 2022;40(11):1175–85. 10.1007/s11604-022-01294-x
5. Fine SW, Argani P, DeMarzo AM, Delahunt B, Sebo TJ, Reuter VE, et al. Expanding the histologic spectrum of mucinous tubular and spindle cell carcinoma of the kidney. Am J Surg Pathol. 2006;30(12):1554–60. 10.1097/01.pas.0000213271.15221.e3
6. Yang C, Cimera RS, Aryeequaye R, Jayakumaran G, Sarungbam J, Al-Ahmadie HA, et al. Adverse histology, homozygous loss of CDKN2A/B, and complex genomic alterations in locally advanced/metastatic renal mucinous tubular and spindle cell carcinoma. Mod Pathol. 2021;34(2):445–56. 10.1038/s41379-020-00667-9
7. Dhillon J, Amin MB, Selbs E, Turi GK, Paner GP, Reuter VE. Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid change. Am J Surg Pathol. 2009;33(1):44–9. 10.1097/PAS.0b013e3181829ed5
8. Paner GP, Srigley JR, Radhakrishnan A, Cohen C, Skinnider BF, Tickoo SK, et al. Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney: Significant immunophenotypic overlap warrants diagnostic caution. Am J Surg Pathol. 2006;30(1):13–9. 10.1097/01.pas.0000180443.94645.50
9. Trpkov K, Hes O, Williamson SR, Adeniran AJ, Agaimy A, Alaghehbandan R, et al. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia. Mod Pathol. 2021;34(7):1392–424. 10.1038/s41379-021-00779-w
10. Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, World Health O, International Agency for Research on C. WHO classification of tumours of soft tissue and bone. 4th edition. ed. Lyon: IARC Press; 2013; 468 pages illustrations (chiefly color).
11. Wei S, Al-Saleem T. The pathology and molecular genetics of sarcomatoid renal cell carcinoma: A mini-review. J Kidney Cancer VHL. 2017;4(2):19–23. 10.15586/jkcvhl.2017.70
12. Zhao M, He XL, Teng XD. Mucinous tubular and spindle cell renal cell carcinoma: A review of clinicopathologic aspects. Diagn Pathol. 2015;10:168. 10.1186/s13000-015-0402-1
13. Thway K, du Parcq J, Larkin JM, Fisher C, Livni N. Metastatic renal mucinous tubular and spindle cell carcinoma. Atypical behavior of a rare, morphologically bland tumor. Ann Diagn Pathol. 2012;16(5):407–10. 10.1016/j.anndiagpath.2011.04.001
14. Furubayashi N, Taguchi K, Negishi T, Miura A, Sato Y, Miyoshi M, et al. Cytoreductive nephrectomy after combination of nivolumab plus ipilimumab for mucinous tubular and spindle cell carcinoma of the kidney with bone metastases: A case report. In Vivo. 2022;36(1):510–21. 10.21873/invivo.12732
15. Bani-Hani AH, Leibovich BC, Lohse CM, Cheville JC, Zincke H, Blute ML. Associations with contralateral recurrence following nephrectomy for renal cell carcinoma using a cohort of 2,352 patients. J Urol. 2005;173(2):391–4. 10.1097/01.ju.0000148951.71353.8b
16. EAU Guidelines on Renal Cell Carcinoma. EAU Annual Congress Paris 2024; Arnhem, The Netherlands: EAU Guidelines Office; 2024.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.